<qa>  What is RECIST 1.1?2. Lesions that have had external beam radiotherapy EBRT or loco-regional therapies such as radiofrequency RF ablation or chemoembolization must show evidence of progressive disease based on RECIST 1.1 to be deemed a target lesion. 